Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

US drug pricing: could the industry regulate itself?

Pharmaceutical price hikes are nothing new, but increased criticism from the public and politicians does seem to have instilled a new sense of social responsibility, at least for some companies. A 10% self-imposed drug cap initiated by Allergan and supported by several other big companies, including Teva and Insys, does seem to be holding up. Could industry self-regulation play a larger role in US drug pricing in the future, or is it all smoke and mirrors?

Free download worth over $5000
Download our 2018 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM

Go Top